Skip to main content

WA42293 PRM-151-303: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

Clinical Trial Grant
Duke Scholars

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Genentech, Inc.

Start Date

January 12, 2022

End Date

December 31, 2025
 

Administered By

Medicine, Pulmonary, Allergy, and Critical Care Medicine

Awarded By

Genentech, Inc.

Start Date

January 12, 2022

End Date

December 31, 2025